Antihyperlipidaemic agents.
D000818:Animals; D002784:Cholesterol / Q000097:blood; D002914:Chylomicrons / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D004285:Dogs; D004591:Electrophoresis, Polyacrylamide Gel; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006218:Halofenate / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy / Q000235:genetics; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007475:Ion Exchange Resins; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D009539:Nicotinic Acids / Q000031:analogs & derivatives / Q000627:therapeutic use; D013045:Species Specificity; D013329:Structure-Activity Relationship; D014280:Triglycerides / Q000097:blood; D014461:Ultracentrifugation
D002914:Chylomicrons; D005230:Fatty Acids, Nonesterified; D000960:Hypolipidemic Agents; D007475:Ion Exchange Resins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D009539:Nicotinic Acids; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate; D006218:Halofenate